Article

eyeonics cuts number of required implants

Aliso Viejo, CA—eyeonics Inc. is reducing the number of implants it requires ophthalmic surgeons to perform before providing credentials for crystalens IOL implantation.

Aliso Viejo, CA-eyeonics Inc. is reducing the number of implants it requires ophthalmic surgeons to perform before providing credentials for crystalens IOL implantation.

The company now will issue credentials after surgeons perform implants on five patients (10 eyes) instead of 10 patients (20 eyes). Company Chairman and Chief Executive Officer J. Andy Corley said the process was streamlined after feedback from 300 credentialed surgeons. Another 200 surgeons are in the credentialing process.

"I believe that eyeonics is offering surgeons an easier way to become credentialed, but at the same time they teach methods to achieve accuracy in measurements and ultimately better patient outcomes," agreed Richard L. Lindstrom, MD, FACS, founder of Minnesota Eye Consultants, P.A., and adjunct professor emeritus, University of Minnesota, Minneapolis.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.